Prestige Consumer Healthcare Total Liabilities and Share Holders Equity 2010-2024 | PBH

Prestige Consumer Healthcare total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
Prestige Consumer Healthcare Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2024 $3,318
2023 $3,354
2022 $3,671
2021 $3,429
2020 $3,514
2019 $3,441
2018 $3,761
2017 $3,911
2016 $2,949
2015 $2,642
2014 $1,796
2013 $1,740
2012 $1,758
2011 $1,057
2010 $791
2009 $801
Prestige Consumer Healthcare Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-09-30 $3,317
2024-06-30 $3,308
2024-03-31 $3,318
2023-12-31 $3,340
2023-09-30 $3,333
2023-06-30 $3,346
2023-03-31 $3,354
2022-12-31 $3,750
2022-09-30 $3,679
2022-06-30 $3,682
2022-03-31 $3,671
2021-12-31 $3,659
2021-09-30 $3,676
2021-06-30 $3,559
2021-03-31 $3,429
2020-12-31 $3,469
2020-09-30 $3,434
2020-06-30 $3,450
2020-03-31 $3,514
2019-12-31 $3,464
2019-09-30 $3,465
2019-06-30 $3,461
2019-03-31 $3,441
2018-12-31 $3,668
2018-09-30 $3,698
2018-06-30 $3,769
2018-03-31 $3,761
2017-12-31 $3,898
2017-09-30 $3,902
2017-06-30 $3,900
2017-03-31 $3,911
2016-12-31 $2,811
2016-09-30 $2,831
2016-06-30 $2,878
2016-03-31 $2,949
2015-12-31 $2,641
2015-09-30 $2,627
2015-06-30 $2,637
2015-03-31 $2,642
2014-12-31 $2,681
2014-09-30 $2,726
2014-06-30 $1,854
2014-03-31 $1,796
2013-12-31 $1,865
2013-09-30 $1,808
2013-06-30 $1,736
2013-03-31 $1,740
2012-12-31 $1,731
2012-09-30 $1,788
2012-06-30 $1,753
2012-03-31 $1,758
2011-12-31 $1,046
2011-09-30 $1,055
2011-06-30 $1,049
2011-03-31 $1,057
2010-12-31 $1,054
2010-09-30 $791
2010-06-30 $776
2010-03-31 $791
2009-12-31 $787
2009-09-30 $799
2009-06-30 $797
2009-03-31 $801
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.893B $1.125B
Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $221.767B 27.38
Boston Scientific (BSX) United States $151.377B 43.52
Stryker (SYK) United States $149.082B 32.08
EssilorLuxottica (ESLOY) France $125.055B 0.00
Medtronic (MDT) Ireland $117.214B 17.41
Lonza Group Ag (LZAGY) Switzerland $45.950B 0.00
Haleon (HLN) United Kingdom $43.139B 28.03
GE HealthCare Technologies (GEHC) United States $40.136B 20.82
ResMed (RMD) United States $37.119B 30.50
Terumo (TRUMY) Japan $28.886B 41.07
Koninklijke Philips (PHG) Netherlands $25.642B 19.63
Zimmer Biomet Holdings (ZBH) United States $22.107B 14.07
Insulet (PODD) United States $19.438B 77.40
Baxter (BAX) United States $16.737B 10.89
Smith & Nephew SNATS (SNN) United Kingdom $11.065B 0.00
BellRing Brands (BRBR) United States $10.084B 40.57
Sunny Optical Technology (SNPTF) China $9.976B 0.00
Bio-Rad Laboratories (BIO) United States $9.966B 33.87
Demant (WILYY) Denmark $8.735B 0.00
Lantheus Holdings (LNTH) United States $6.433B 14.95
ICU Medical (ICUI) United States $4.121B 39.23
Envista Holdings (NVST) United States $3.678B 27.40
Haemonetics (HAE) United States $3.430B 16.74
Perrigo (PRGO) Ireland $3.366B 9.91
GN Store Nord (GNNDY) Denmark $3.027B 19.41
Shandong Weigao Medical Polymer (SHWGF) China $2.989B 0.00
QuidelOrtho (QDEL) United States $2.927B 18.84
Neogen (NEOG) United States $2.495B 28.75
LeMaitre Vascular (LMAT) United States $2.247B 54.60
AtriCure (ATRC) United States $2.067B 0.00
Green Thumb Industries (GTBIF) United States $1.464B 25.63
InMode (INMD) Israel $1.462B 8.79
AdaptHealth (AHCO) United States $1.430B 10.22
BioLife Solutions (BLFS) United States $1.313B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.270B 0.00
Owens & Minor (OMI) United States $1.150B 8.99
Evolus (EOLS) United States $0.922B 0.00
Phibro Animal Health (PAHC) United States $0.887B 15.64
CeriBell (CBLL) United States $0.833B 0.00
Curaleaf Holdings (CURLF) Canada $0.830B 0.00
Capricor Therapeutics (CAPR) United States $0.649B 0.00
VAREX IMAGING (VREX) United States $0.561B 24.73
Surmodics (SRDX) United States $0.511B 0.00
Omeros (OMER) United States $0.502B 0.00
Cresco Labs (CRLBF) United States $0.432B 0.00
Verano Holdings (VRNOF) United States $0.429B 0.00
Valneva SE (VALN) France $0.412B 0.00
ZimVie (ZIMV) United States $0.401B 33.77
Quanterix (QTRX) United States $0.370B 0.00
Cerus (CERS) United States $0.360B 0.00
Viemed Healthcare (VMD) United States $0.322B 30.67
Sanara MedTech (SMTI) United States $0.317B 0.00
Biote (BTMD) United States $0.309B 6.76
OraSure Technologies (OSUR) United States $0.291B 19.50
Canopy Growth (CGC) Canada $0.265B 0.00
Zynex (ZYXI) United States $0.263B 55.13
High Tide (HITI) Canada $0.239B 0.00
Sanuwave Health (SNWV) United States $0.233B 3.28
Utah Medical Products (UTMD) United States $0.208B 15.52
Aurora Cannabis (ACB) Canada $0.203B 0.00
Brainsway (BWAY) Israel $0.197B 104.70
MacroGenics (MGNX) United States $0.190B 0.00
Organigram Holdings (OGI) Canada $0.189B 0.00
TerrAscend (TSNDF) Canada $0.154B 0.00
TriSalus Life Sciences (TLSI) United States $0.149B 0.00
FitLife Brands (FTLF) United States $0.145B 18.27
Quipt Home Medical (QIPT) United States $0.135B 0.00
Jin Medical (ZJYL) China $0.125B 0.00
Fonar (FONR) United States $0.102B 11.54
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Veru (VERU) United States $0.089B 0.00
InterCure (INCR) Israel $0.077B 0.00
Exagen (XGN) United States $0.072B 0.00
INLIF (INLF) $0.071B 0.00
Rockwell Medical (RMTI) United States $0.066B 34.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
Apyx Medical (APYX) United States $0.055B 0.00
Cytosorbents (CTSO) United States $0.055B 0.00
Modular Medical (MODD) United States $0.051B 0.00
Ayr Wellness (AYRWF) United States $0.051B 0.00
United-Guardian (UG) United States $0.050B 14.35
ImmuCell (ICCC) United States $0.048B 0.00
Safety Shot (SHOT) United States $0.031B 0.00
Nephros (NEPH) United States $0.018B 0.00
Allurion Technologies (ALUR) United States $0.015B 0.00
Innovative Eyewear (LUCY) United States $0.013B 0.00
Flora Growth (FLGC) United States $0.011B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
Sharps Technology (STSS) United States $0.001B 0.00
SNDL (SNDL) Canada $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00